Buprenorphine, Naloxone Drug Combination
"Buprenorphine, Naloxone Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESIC with naloxone, a NARCOTIC ANTAGONIST to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIATE SUBSTITUTION THERAPY.
| Descriptor ID |
D000069479
|
| MeSH Number(s) |
D03.132.577.249.150.500 D03.132.577.249.706.275 D03.605.497.150.500 D03.605.497.750.275 D03.633.400.686.150.500 D03.633.400.686.750.275 D04.615.723.795.150.500 D04.615.723.795.706.275 D26.310.352
|
| Concept/Terms |
Buprenorphine, Naloxone Drug Combination- Buprenorphine, Naloxone Drug Combination
- Buprenorphine-Naloxone Drug Combination
- Combination, Buprenorphine-Naloxone Drug
- Drug Combination, Buprenorphine-Naloxone
- Buprenorphine-Naloxone
- Buprenorphine Naloxone
- Naloxone, Buprenorphine
- Buprenorphine-Naloxone Combination
- Buprenorphine Naloxone Combination
- Combination, Buprenorphine-Naloxone
- Buprenorphine Naloxone Drug Combination
|
Below are MeSH descriptors whose meaning is more general than "Buprenorphine, Naloxone Drug Combination".
- Chemicals and Drugs [D]
- Heterocyclic Compounds [D03]
- Alkaloids [D03.132]
- Opiate Alkaloids [D03.132.577]
- Morphinans [D03.132.577.249]
- Buprenorphine [D03.132.577.249.150]
- Buprenorphine, Naloxone Drug Combination [D03.132.577.249.150.500]
- Naloxone [D03.132.577.249.706]
- Buprenorphine, Naloxone Drug Combination [D03.132.577.249.706.275]
- Heterocyclic Compounds, Bridged-Ring [D03.605]
- Morphinans [D03.605.497]
- Buprenorphine [D03.605.497.150]
- Buprenorphine, Naloxone Drug Combination [D03.605.497.150.500]
- Naloxone [D03.605.497.750]
- Buprenorphine, Naloxone Drug Combination [D03.605.497.750.275]
- Heterocyclic Compounds, Fused-Ring [D03.633]
- Heterocyclic Compounds, 4 or More Rings [D03.633.400]
- Morphinans [D03.633.400.686]
- Buprenorphine [D03.633.400.686.150]
- Buprenorphine, Naloxone Drug Combination [D03.633.400.686.150.500]
- Naloxone [D03.633.400.686.750]
- Buprenorphine, Naloxone Drug Combination [D03.633.400.686.750.275]
- Polycyclic Compounds [D04]
- Polycyclic Aromatic Hydrocarbons [D04.615]
- Phenanthrenes [D04.615.723]
- Morphinans [D04.615.723.795]
- Buprenorphine [D04.615.723.795.150]
- Buprenorphine, Naloxone Drug Combination [D04.615.723.795.150.500]
- Naloxone [D04.615.723.795.706]
- Buprenorphine, Naloxone Drug Combination [D04.615.723.795.706.275]
- Pharmaceutical Preparations [D26]
- Drug Combinations [D26.310]
- Buprenorphine, Naloxone Drug Combination [D26.310.352]
Below are MeSH descriptors whose meaning is more specific than "Buprenorphine, Naloxone Drug Combination".
This graph shows the total number of publications written about "Buprenorphine, Naloxone Drug Combination" by people in this website by year, and whether "Buprenorphine, Naloxone Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Buprenorphine, Naloxone Drug Combination" by people in Profiles.
-
Health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in Federally Qualified Health Centers and other primary care settings. PLoS One. 2022; 17(10):e0276066.